Effects Whole Body Vibration in Ergospirometrics Parameters and Quality of Life
EWBVEPQL
1 other identifier
interventional
35
1 country
1
Brief Summary
This study makes sure that the training of whole body vibration induces changes in ergospirometric parameters, in strength and influence in quality of life in healthy elderly. A case that is run like a vibration training combined, increasing strength and VO2.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for phase_1 healthy
Started Feb 2011
Longer than P75 for phase_1 healthy
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2012
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2012
CompletedFirst Submitted
Initial submission to the registry
February 9, 2012
CompletedFirst Posted
Study publicly available on registry
February 24, 2012
CompletedFebruary 24, 2012
February 1, 2012
1 year
February 9, 2012
February 18, 2012
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
VO2
change to maximal oxygen consumption (ml.kg.min)in ergospirometric test after 03 months training in vibrating platform twice per weeck.
03 MONTHS IN INTERVENTION
Secondary Outcomes (1)
quality of life
03 month
Study Arms (1)
WHOLE BODY VIBRATION
EXPERIMENTALSEARCH THE CARDIOPULMONARY EFFECTS IN WHOLE BODY VIBRATION IN HEALTH ELDERLY
Interventions
03 MONTHS, TWICE PER WEEK
Eligibility Criteria
You may qualify if:
- aged 60 to 74 years
- sedentary or irregularly active according to the IPAQ short form with no known diseases
You may not qualify if:
- smoking
- acute hernia
- thrombosis
- labyrinthitis
- diabetes
- hemodynamic instability
- obesity
- osteoporosis
- neuromuscular diseases
- pulmonary comorbidities
- heart disease
- electrocardiographic changes during exercise
- taking medications that affected bone metabolism or muscle and don't adapt to any of the protocols
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Federal University of Pernambuco
Recife, Pernambuco, 50670-901, Brazil
Study Officials
- STUDY DIRECTOR
Maíra F Pessoa, MS
Universidade Federal de Pernambuco
- STUDY CHAIR
Rafaela B Sá, MS
Universidade Federal de Pernambuco
Study Design
- Study Type
- interventional
- Phase
- phase 1
- Allocation
- NA
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- graduate
Study Record Dates
First Submitted
February 9, 2012
First Posted
February 24, 2012
Study Start
February 1, 2011
Primary Completion
February 1, 2012
Study Completion
February 1, 2012
Last Updated
February 24, 2012
Record last verified: 2012-02